对于罕见疾病的孤儿药物开发的挑战和进展
Abhijit Debnath1, Rupa Mazumder1, Avijit Mazumder1
1Department of Pharmaceutics, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida-201306, Uttar Pradesh, India.
Current pharmaceutical biotechnology
|July 2, 2025
概括
孤儿药物开发面临着科学,经济和监管方面的障碍. 像人工智能和基因疗法这样的技术进步正在彻底改变罕见疾病的治疗方法,但在可访问性和资金方面的挑战仍然存在.
科学领域:
- 生物医学研究生物医学研究
- 药物开发 药物开发
- 罕见疾病 罕见疾病
背景情况:
- 罕见疾病影响全球数百万人,为研究和治疗带来了独特的挑战.
- 孤儿药物开发是复杂的,涉及科学,经济和监管障碍.
- 现有的医疗保健系统和制药研究在解决罕见疾病方面面临重大困难.
研究的目的:
- 审查孤儿药物开发的不断变化的格局.
- 分析罕见病研究中的科学,经济和监管挑战.
- 突出技术突破和创新方法,改变罕见疾病治疗.
主要方法:
- 关于孤儿药物开发的综合文献综述.
- 对科学,经济和监管因素的分析.
- 检查技术进步和治疗策略.
主要成果:
- 人工智能,下一代测序和个性化医学是进步的关键驱动力.
- 基因疗法,基于细胞的治疗方法和药物重新定位对以前无法治疗的疾病有很大的希望.
- 国际合作和不断发展的监管框架加速了孤儿药物的批准.
结论:
- 尽管取得了进展,但诊断,治疗可获得性和可持续融资方面的差距仍然存在.
- 加强国际合作和患者登记册至关重要.
- 公私伙伴关系和技术创新对于解决尚未满足的罕见病需求至关重要.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
857
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
857
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Drug Administration and Therapy Phases: Overview
770
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
770
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K


